Trump’s Second Term Could Turn LDT Regulation on its Head

Trump’s Second Term Could Turn LDT Regulation on its Head

Source: 
Medical Devices and Diagnostics Industry
snippet: 
  • Trump's new term could lead to the repeal of FDA's LDT rule, reverting it to previous regulations or alternative oversight.
  • FDA’s final rule treats LDTs as medical devices, imposing stricter requirements, and raising concerns in the lab industry.
  • The ACLA is challenging the FDA’s LDT rule, while the VALID Act proposes an alternative framework.